Christopher Pierce

PRLD

Christopher Pierce serves as EVP and Chief of Business Oper at Prelude Therapeutics Incorporated (PRLD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$882.4K

Net Position

Net Seller

$882.4K

Companies Traded

PRLD

Active Period

Apr 2021 – Sep 2021

4 total trades

Most Recent

Sell PRLD

Sep 7, 2021 · $708.5K

Christopher Pierce's Insider Trading at Prelude Therapeutics Incorporated (PRLD)

Buys

0 · $0.00

Sells

4 · $882.4K

Total Shares Bought

Total Shares Sold

21,323

PRLD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 7, 2021	Sell	17,000	$41.68	$708.5K	17,407
Apr 30, 2021	Sell	3,295	$40.29	$132.8K	3,750
Apr 15, 2021	Sell	200	$40.00	$8.0K	3,750
Apr 9, 2021	Sell	828	$40.08	$33.2K	3,750

Related Insiders

David P Bonita

director, 10 percent owner:

PRLDBuy · Apr 23, 2026

ORBIMED ADVISORS LLC

director, 10 percent owner:

PRLDBuy · Apr 23, 2026

BAKER BROS. ADVISORS LP

director, 10 percent owner:

PRLDBuy · Apr 22, 2026

Jane Huang

President, CMO

PRLDSell · Oct 4, 2025

Explore More Insider Trading Data

PRLD Insider Trading Activity

View all insider trades at Prelude Therapeutics Incorporated

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity